A cavernous angioma with symptomatic hemorrhage (CASH) is more likely to rebleed for several years while conventional MRI signatures of hemorrhage may disappear after a few weeks. We aimed to investigate whether perfusion or permeability derivations of dynamic contrast-enhanced quantitative perfusion-MRI (DCEQP) can distinguish a lesion that had bled earlier or predict subsequent lesional bleeding/growth after DCEQP. Machine learning and Bayesian model selection showed that perfusion imaging may distinguish cases with CASH 3–12 months prior to the scan (diagnostic biomarker) while a combination of permeability and perfusion derivations may predict bleeding/growth in the subsequent year (prognostic biomarker).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords